CannTrust Holdings Inc. (“CannTrust” or the “Company” | TSX: TRST), a licensed producer of medical cannabis under the Health Canada Access to Cannabis for Medical Purposes Regulation (“ACMPR”) program, today announced financial and operating results for the three months ending March 31, 2018. All amounts expressed are in Canadian dollars.
Revenue for the three month period ended March 31, 2018 was $7,839,847 compared to $3,033,245 in the comparable 2017 period.